dMMR prediction from colorectal cancer histopathology: Leveraging non-tumor and low-magnification regions.
2/5 보강
OpenAlex 토픽 ·
Genetic factors in colorectal cancer
AI in cancer detection
Colorectal Cancer Screening and Detection
[BACKGROUND AND OBJECTIVE] Colorectal cancer is the second leading cause of cancer-related mortality worldwide, posing a substantial burden on healthcare systems.
APA
Liisa Petäinen, Juha P. Väyrynen, et al. (2026). dMMR prediction from colorectal cancer histopathology: Leveraging non-tumor and low-magnification regions.. Computer methods and programs in biomedicine, 280, 109317. https://doi.org/10.1016/j.cmpb.2026.109317
MLA
Liisa Petäinen, et al.. "dMMR prediction from colorectal cancer histopathology: Leveraging non-tumor and low-magnification regions.." Computer methods and programs in biomedicine, vol. 280, 2026, pp. 109317.
PMID
41875848 ↗
Abstract 한글 요약
[BACKGROUND AND OBJECTIVE] Colorectal cancer is the second leading cause of cancer-related mortality worldwide, posing a substantial burden on healthcare systems. Identifying DNA mismatch repair deficiency (dMMR) is critical for guiding treatment, yet conventional methods rely on labor-intensive DNA analysis. While deep-learning approaches have shown promise for predicting dMMR from histopathological images, most studies focus exclusively on tumor regions and single-scale representations. This study systematically evaluates the predictive value of tumor and non-tumor regions across multiple magnifications for dMMR prediction from whole-slide images (WSIs).
[METHODS] A total of 24 different modeling approaches were evaluated, varying by tissue origin (tumor vs. non-tumor), magnification level (5x and 20x), and tile embedding strategy, including digital pathology foundation models. Tile embeddings were further trained with 1228 WSIs using multiple-instance learning (MIL) based approach. The best-performing configurations were selected for external evaluation. External testing was carried out on two independent cohorts consisting of 1010 and 457 WSIs, respectively.
[RESULTS] Non-tumorous regions demonstrated measurable predictive value, although performance remained lower than that obtained from tumor regions (F1 = 0.896, precision = 0.888, sensitivity = 0.594, specificity = 0.982). Among the nine models selected during internal validation, the top three models-one multi-scale approach and two models trained on 20x tumor regions-achieved F1 scores of 0.870-0.889 with precision of 0.885-0.920, sensitivity of 0.852, and specificity of 0.889-0.926. On external validation, the top three models, all based on foundation-model tile embeddings, achieved F1 scores of 0.916-0.919 on the first cohort and 0.928-0.934 on the second cohort. Across cohorts, specificity remained consistently high (0.964-0.992), while sensitivity ranged from 0.500 to 0.682.
[CONCLUSION] This study demonstrates that dMMR status in colorectal cancer can be effectively predicted from histopathological WSIs using MIL-based models, with moderate generalizability across independent cohorts. In addition to confirming the predictive value of tumor regions, the results reveal that non-tumorous tissue also contains detectable predictive signals, suggesting that microenvironmental features may contribute to dMMR-associated histological patterns. Furthermore, the use of foundation model-derived embeddings improved generalizability across datasets. Future work should explore integrating non-tumor tissue features and clinical data to further improve predictive performance.
[METHODS] A total of 24 different modeling approaches were evaluated, varying by tissue origin (tumor vs. non-tumor), magnification level (5x and 20x), and tile embedding strategy, including digital pathology foundation models. Tile embeddings were further trained with 1228 WSIs using multiple-instance learning (MIL) based approach. The best-performing configurations were selected for external evaluation. External testing was carried out on two independent cohorts consisting of 1010 and 457 WSIs, respectively.
[RESULTS] Non-tumorous regions demonstrated measurable predictive value, although performance remained lower than that obtained from tumor regions (F1 = 0.896, precision = 0.888, sensitivity = 0.594, specificity = 0.982). Among the nine models selected during internal validation, the top three models-one multi-scale approach and two models trained on 20x tumor regions-achieved F1 scores of 0.870-0.889 with precision of 0.885-0.920, sensitivity of 0.852, and specificity of 0.889-0.926. On external validation, the top three models, all based on foundation-model tile embeddings, achieved F1 scores of 0.916-0.919 on the first cohort and 0.928-0.934 on the second cohort. Across cohorts, specificity remained consistently high (0.964-0.992), while sensitivity ranged from 0.500 to 0.682.
[CONCLUSION] This study demonstrates that dMMR status in colorectal cancer can be effectively predicted from histopathological WSIs using MIL-based models, with moderate generalizability across independent cohorts. In addition to confirming the predictive value of tumor regions, the results reveal that non-tumorous tissue also contains detectable predictive signals, suggesting that microenvironmental features may contribute to dMMR-associated histological patterns. Furthermore, the use of foundation model-derived embeddings improved generalizability across datasets. Future work should explore integrating non-tumor tissue features and clinical data to further improve predictive performance.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.